Lexicon Pharmaceuticals, Inc.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of pharmaceutical products. The company offers XERMELO, an orally-delivered small molecule drug candidate for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analog therapy in adults. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the treatment of type 1 and is in Phase III clinical trials for the treatment of type 2 diabetes; LX9211, which is in Phase I clinical development for the treatment of neuropathic pain; and LX2761 that is in Phase I clinical development for the treatment of diabetes. The company has strategic collaboration and license agreements with Ipsen Pharma SAS; Bristol-Myers Squibb Company; and Genentech, Inc. Lexicon Pharmaceuticals, Inc. was founded in 1995 and is headquartered in The Woodlands, Texas. Show More...
-
Website http://www.lexpharma.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 0.63 USD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD -2.38 -2.38 -1.61 -1.42 -1.31 -0.05 -1.27 -1.17 -1.14 1.16 0.74 Dividends USD Payout Ratio % * Shares Mil 43.0 49.0 70.0 73.0 76.0 104.0 104.0 105.0 106.0 117.0 117.0 Book Value Per Share * USD 5.12 2.47 3.64 2.53 0.75 1.91 1.78 0.74 -0.28 1.55 0.51 Free Cash Flow Per Share * USD -1.93 -1.79 -1.36 -1.25 -1.27 -0.87 1.34 -1.92 -1.47 0.97 Return on Assets % -32.59 -29.15 -27.47 -32.24 -26.91 -0.83 -25.02 -28.3 -33.45 37.08 27.12 Financial Leverage (Average) 1.49 1.45 1.39 1.61 1.66 2.29 3.02 8.38 3.57 6.76 Return on Equity % -49.55 -42.68 -39.06 -47.67 -44.16 -1.64 -63.81 -123.2 -938.23 286.97 Return on Invested Capital % -39.34 -38.11 -35.36 -42.44 -34.36 0.37 -42.17 -44.72 -40.0 49.07 38.3 Interest Coverage -36.44 -44.97 -51.13 -51.83 -43.55 0.3 -20.54 -19.29 -4.8 7.0 4.83 Current Ratio 19.93 13.36 12.63 6.97 8.21 4.33 2.17 2.59 4.72 5.17 3.63 Quick Ratio 19.66 13.19 12.28 6.73 7.57 4.25 2.15 2.54 4.52 5.02 3.47 Debt/Equity 0.11 0.08 0.08 0.12 0.31 0.36 0.54 4.44 2.01 4.28